Nitin Jain, M.D. @CLLdoc Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX discusses the nd to Chemotherapy in CLL Most Likely as Targeted and Immunotherapy Move to Frontline